0001437749-18-000320.txt : 20180105
0001437749-18-000320.hdr.sgml : 20180105
20180105134116
ACCESSION NUMBER: 0001437749-18-000320
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171204
FILED AS OF DATE: 20180105
DATE AS OF CHANGE: 20180105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jensen Glenn
CENTRAL INDEX KEY: 0001369173
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14602
FILM NUMBER: 18512914
MAIL ADDRESS:
STREET 1: 73-4460 QUEEN KAAHUMANU HWY #102
CITY: KAILUA-KONA
STATE: HI
ZIP: 96740
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYANOTECH CORP
CENTRAL INDEX KEY: 0000768408
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 911206026
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 73-4460 QUEEN KAAHUMANU HWY
STREET 2: SUITE 102
CITY: KAILUA KONA
STATE: HI
ZIP: 96740
BUSINESS PHONE: 8083261353
MAIL ADDRESS:
STREET 1: 73-4460 QUEEN KAAHUMANU HWY
STREET 2: SUITE 102
CITY: KAILUA-KONA
STATE: HI
ZIP: 96740
4
1
rdgdoc.xml
FORM 4
X0306
4
2017-12-04
0000768408
CYANOTECH CORP
CYAN
0001369173
Jensen Glenn
73-4460 QUEEN KAAHUMANU HWY #102
KAILUA-KONA
HI
96740
1
VP of Manufacturing
Cyanotech Corporation Common Stock
2017-12-04
4
M
0
2000
1.60
A
12333
D
Cyanotech Corporation Common Stock
375
I
By Spouse
Cyanotech common stock options
1.60
2017-12-04
4
M
0
2000
0
D
2018-02-21
Cyanotech common stock
2000
0
D
Cyanotech common stock options
2.0800
2019-04-30
Cyanotech common stock
10000
10000
D
Cyanotech common stock options
3.5800
2021-06-30
Cyanotech common stock
8000
8000
D
Cyanotech common stock options
3.8200
2021-08-28
Cyanotech common stock
2000
2000
D
Cyanotech common stock options
3.8200
2021-08-28
Cyanotech common stock
35000
35000
D
Cyanotech common stock options
5.8400
2022-07-18
Cyanotech common stock
10000
10000
D
Restricted stock units
Cyanotech common stock
500
500
D
Mr Jensen acquired 2,000 stock options on 2/22/2008, of which 200 options became exercisable on 2/22/2009, 400 options became exercisable on 2/22/2010, 600 options became exercisable on 2/22/2011 and 800 options became exercisable on 2/22/2012.
Mr Jensen acquired 10,000 stock options on 4/30/2009, of which 1,000 options became exercisable on 4/30/2010, 2,000 options became exercisable on 4/30/2011, 3,000 options became exercisable on 4/30/2012 and 4,000 options became exercisable on 4/30/2013.
Mr Jensen acquired 8,000 stock options on 7/1/2011, of which 800 options became exercisable on 7/1/2011, 1,600 options became exercisable on 7/1/2012, 2,400 options became exercisable on 7/1/2013 and 3,200 options became exercisable on 7/1/2014.
Mr Jensen acquired 2,000 stock options on 8/29/2011, of which 200 options became exercisable on 8/29/2011, 400 options became exercisable on 8/29/2012, 600 options became exercisable on 8/29/2013 and 800 options became exercisable on 8/29/2014.
Mr Jensen acquired 35,000 stock options on 8/29/2011, of which 7,000 options became exercisable on 8/29/2012, 7,000 options became exercisable on 8/29/2013, 7,000 options became exercisable on 8/29/2014, 7,000 options became exercisable on 8/29/2015 and 7,000 options became exercisable on 8/29/2016.
Mr Jensen acquired 10,000 stock options on 7/19/2012, of which 2,500 options became exercisable on 7/19/2013, 2,500 options became exercisable on 7/19/2014, 2,500 options became exercisable on 7/19/2015 and 2,500 options became exercisable on 7/19/2016.
Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock.
The restricted stock units shall vest as to 167 shares on 4/5/2018, 167 shares on 4/5/2019 and 166 shares on 4/5/2020, in each case subject to continued service with Cyanotech on the vesting date.
/s/ Dan Sprague, by Power of Attorney
2018-01-05